Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.


Bee Vectoring Technologies International Inc. (C:BEE)

Business Focus: Agricultural Chemicals (NEC)

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for BEE within the last 6 months
See all filings within the past 6 months

Company News

Oct 06, 2022 08:00 ET
Bee Vectoring Technologies Announces Paid Demonstration Trials Secured with Mexican Growers of CR-7 Biological Fungicide
Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - October 6, 2022) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") is pleased to announce the first paid demonstration trials of BVT's Clonostachys rosea CR-7 (CR-7) proprietary biological fungicide with two berry growers in Mexico. The trials will gather data on bee vectoring with CR-7 on common fungal diseases including Botrytis (gray mold).
Read full article
Sep 23, 2022 15:12 ET
Bee Vectoring Technologies Highlight Reel
Copyright (c) 2022 TheNewswire - All rights reserved.
Read full article
See more news stories

Valuation Ratios

Price to Sales - TTM
Price to Book - most recent quarter
Price to Cash Flow per share - TTM
Price to Free Cash Flow per share - TTM
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Sep 15, 20227,7382,173
Aug 31, 20225,565-17,207
Aug 15, 202222,77216,282
See Short Report

Business Summary

Sector:  Basic Materials Industry:  Agricultural Chemicals

Bee Vectoring Technologies International Inc. is a Canada-based agriculture technology company. The Company is focused on the control of pests and enhancement of crops and ornamentals through the use of biological controls in a variety of application processes. It is commercializing a patented and patent-pending technology specifically designed to utilize bees as natural delivery mechanisms for a variety of powdered mixtures consisting of organic compounds, which promotes the growth of the crops. The bees walk through the powder mixtures as they exit their hive, and the mixture becomes temporarily attached to their legs enroots to the flowers of the crops of interest. Its proprietary carrier Vectorite, which allows the bees to effectively pick up the inoculums on their way out of the hive. It has its own bio control organic inoculant fungi, BVT-CR7, used to inhibit and control certain pathogens in crops such as strawberries, blueberries, tomatoes, canola, sunflowers.

See business summary



Search (past week) for $BEE.CA